INCI · — · CIR review pending · used in 3 products
수용성프로테오글리칸
SOLUBLE PROTEOGLYCAN
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.